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A B S T R A C T
Purpose: The group of the rare progressive myoclonic epilepsies (PME) include a wide spectrum of
mitochondrial and metabolic diseases. In juvenile and adult ages, MERRF (myoclonic epilepsy with
ragged red ﬁbres) is the most common form. The underlying genetic defect in most patients with the
syndrome of MERRF is a mutation in the tRNALys gene, but mutations were also detected in the tRNAPhe
gene.
Method: Here, we describe a 40 year old patient with prominent myoclonic seizures since 39 years of age
without a mutation in the known genes who underwent intensive clinical, genetic and functional
workup.
Results: The patient had a slight mental retardation and a severe progressive hearing loss based on a
defect of the inner ear on both sides. Ictal electroencephalography (EEG) showed bilateral occipital and
generalized spikes and polyspikes induced and aggravated by photostimulation. A cranial magnetic
resonance imaging (cMRI) detected a global cortical atrophy of the brain and mild periventricular white
matter lesions. The electromyography (EMG) was normal but the muscle biopsy showed abundant
ragged red ﬁbres. Sequencing of the mitochondrial DNA from the skeletal muscle biopsy revealed a novel
heteroplasmic mutation (m.4279A>G) in the tRNAIle gene which was functionally relevant as tested in
single skeletal muscle ﬁbre investigations.
Conclusion: Mutations in tRNAIle were described in patients with chronic progressive external
ophthalmoplegia (CPEO), prominent deafness or cardiomyopathy but, up to now, not in patients with
myoclonic epilepsy. The degree of heteroplasmy of this novel mitochondrial DNA mutation was 70% in
skeletal muscle but only 15% in blood, pointing to the diagnostic importance of a skeletal muscle biopsy
also in patients with myoclonic epilepsy.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Progressive myoclonus epilepsies (PME) are a group of rare
syndromes including a broad spectrum of neurodegenerative
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http://dx.doi.org/10.1016/j.seizure.2013.03.003which are deﬁned as sudden, brief involuntary movements
without loss of consciousness. Myoclonus can be induced by
voluntary movements, sensory or tactile triggers. In adulthood,
MERRF (myoclonic epilepsy with ragged red ﬁbres) and MELAS
(mitochondrial myopathy, encephalopathy, lactic acidosis,
stroke-like episodes) might be the most common forms. Muta-
tions were found in the mitochondrial DNA such as tRNALys in case
of MERRF or in tRNALeu in MELAS. In both syndromes, mutations
were also found in tRNAPhe.2 Patients with MERRF present with a
combination of epilepsy including myoclonic seizures inducable
by photic stimulation, myopathy with ragged red ﬁbres,
progressive deafness, dementia and optic atrophy. Rare symp-
toms are cardiomyopathy, retinitis pigmentosa and pyramidal
signs. In up to 80% of patients, one speciﬁc mutation (m.8344A>G)
in tRNALys was described.3 Prominent heteroplasmy, the variable
abundance of the mutation in analyzed tissues, seems to be thevier Ltd. All rights reserved.
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clinical syndrome.4 Electroencephalography (EEG) can show slow
background activity and bursts of generalized or focal epileptic
discharges. In brain magnetic resonance imaging (cMRI), global
atrophy and white matter lesions as well as calciﬁcations of the
basal ganglia were detected.5 Here, we describe a patient who
presents with a classical MERRF phenotype with prominent
myoclonic seizures, but does not carry the typical m.8344A>G
mutation.
2. Methods
Standard protocol approvals and patient consent. The study was
conducted according to the guidelines of the Ethical Committees of
the University Ulm, Bonn and Tu¨bingen, Germany. Written
informed consent was obtained from all individuals.
Muscle histology. Skeletal muscle biopsy was performed
according to standard procedures. For histological and histochem-
ical analysis, 10 mm frozen sections were stained with haematox-
ylin and eosine, modiﬁed Gomori trichrome, cytochrome c oxidase
(COX) and succinate dehydrogenase (SDH).
Biochemical investigations. Cytrate synthase activities were
determined by standard methods. The activity of NADH:CoQ
oxidoreductase (complex I) was measured using a dual-wave-
length spectrophotometer (Aminco DW 2000, SLM Instruments,
Rochester, NY, USA) at 340/380 nm (ered-ox = 5.5 mM1 cm1).
Cytochrome c oxidase (complex IV) activity was measured by
monitoring the oxidation of ferrocytochrome c in its b-band at the
wavelength pair 510/535 nm (ered-ox = 5.9 mM1 cm1).6Fig. 1. Results of the EEG, the cMRI and the muscle biopsy in the index case. (A) The EEG sh
myoclonic jerks of the upper extremities. (B) The cMRI detected a global atrophy of the b
no pathological changes leading to a myopathy, but the muscle biopsy demonstrated a C
oxidase/succinate dehydrogenase (COX/SDH) staining (brown ﬁbres = regular COX expre
(see arrows, right). (For interpretation of the references to colour in this ﬁgure legendDNA mutation analysis. Total DNA was extracted from 10 ml
aliquots of EDTA blood using a salting-out method, and from
muscle biopsy specimens using the QiaAmp DNA Mini Kit (Qiagen,
Germany). For direct sequence analysis of the entire mitochondrial
genome, 28 overlapping PCR fragments were ampliﬁed from
skeletal muscle DNA and sequenced by a commercial sequencing
service (Euroﬁns MWG Operon, Germany). For quantiﬁcation of
m.4279A>G mutation loads by restriction fragment length
analysis (RFLP), we used primers 3922F25 (50-GAACTAGTCT-
CAGGCTTCAACATCG-30) and 4388R20 (50-TGATAGGTGGCACGGA-
GAAT-30) to amplify a product that contained an Eam1104I
restriction site in the presence of the mutant allele. Primer
4388R20 in combination with primer 4252PsiF25 (50-CTCAAACC-
TAAGAAATATGTCTTAT-30) was used to introduce a mismatched
nucleotide (underlined), thus, creating a PsiI restriction site in the
presence of the wild-type allele. Conditions for PCR ampliﬁcation
were as follows: 95 8C/10 min; 33 cycles of 95 8C/15 s, 55 8C/30 s,
72 8C/1 min; and ﬁnally 72 8C/7 min. After restriction endonucle-
ase digestion of the PCR products, DNA fragments were separated
on a 10% polyacrylamide gel and visualized by SYBR Green I
staining (Sigma–Aldrich, Steinherm, Germany). Optical densities of
bands were measured using the ImageJ program. Heteroplasmy
was calculated as the ratio of the sum of mutation-speciﬁc band
amplitudes to the total sum of band amplitudes.
Single-ﬁbre analysis. Genotyping of individual muscle ﬁbres
were performed as described before.7 Brieﬂy, randomly selected
ﬁbres in a 10 mm section of unstained frozen skeletal muscle were
cut and catapulted to tube cap using the P.A.L.M. MicroBeam laser
microdissection system. After incubation at 55 8C/30 min withows bilateral occipital spikes here induced by photic stimulation and combined with
rain and mild periventricular white matter lesions. (C) The electromyography found
OX-deﬁciency in a high quantity of muscle ﬁbres (blue ﬁbres, left) in a cytochrome c
ssion). The modiﬁed Gomori trichrome staining showed abundant ragged red ﬁbres
, the reader is referred to the web version of this article.)
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for PCR-RFLP genotyping. COX and SDH activities of individual
ﬁbres were determined in consecutive sections by histochemical
staining and grey-level determination.7
3. Case report
Clinical investigations. The 40 year old patient presented with
prominent myoclonic seizures since one year which were
aggravated upon movement but also appeared spontaneously.
Other triggers were not observed. In the absence of medication the
patient had myocloni several times daily. He never had complex-
partial nor generalized tonic–clonic seizures. In the family history,
a cousin might be also affected, but she did not accept a
participation in the study as well as the parents of the patient.
In the neurological examination, a severe hearing loss on both sides
was evident. Further neurological pathologies were not found
interictally, but slight deﬁcits were detected in a neuropsycholog-
ical testing: reduction in speed of working memory as well as a
verbal and episodic memory deﬁcit. Tendon reﬂexes were
symmetric and normal and the patient never complained about
muscle cramps, myalgias nor about exercise intolerance. We
excluded the affection of the heart by transthoracal echocardio-
gram and long-term electrocardiogram. A retinits pigmentosa was
not found in the patient; the eye movements were not disturbed.
The patient suffered from a severe progressive hearing loss based
on a defect of the inner ear probably starting in childhood. Without
knowing the genetic basis of the disease, he was initially treated by
valproic acid which reduced the myoclonic jerks only marginally.
Therefore, the medication was later changed to levetiracetam
yielding seizure freedom at a dose of 2000 mg/d. A video-EEG
monitoring showed ictal and interictal bilateral occipital and
generalized spikes and polyspikes. The seizures and epileptic
discharges could be elicited by photic stimulation at frequencies of
20 Hz (Fig. 1A). Background EEG was normal. A cMRI detected a
global atrophy of the brain and periventricular white matter
lesions (Fig. 1B). The electromyography (EMG) was normal, but in
the muscle biopsy abundant ragged red ﬁbres were found (Fig. 1C).
Nerve conduction studies were normal.Fig. 2. Detection of the mitochondrial tRNAIlemutation m.4279A>G. (A) Partial sequence 
arrow indicates the position of the heteroplasmic mutation m.4279A>G. (B) Secondary st
encircled. (C) Quantiﬁcation of m.4279A>G mutation loads by RFLP shows lower mutat
healthy brother; MB, patient’s muscle biopsy; C, control blood; wt, wild-type; mut, mut
single skeletal muscle ﬁbres. Fibres that harboured nearly exclusively mutant mtDNA sh
standard errors of the mean as determined by two different RFLP methods. Fibre type
indicated as shown in the inset. Note the very high threshold that is required for respBiochemistry and Genetics. Enzymatic measurements in muscle
homogenate showed a marked decrease in activities of complex I
(1.23 U/g wet weight, in 48 controls 2.48  0.80) and complex IV
(5.66 U/g wet weight, in controls 9.63  2.84) of the respiratory chain
at almost unchanged citrate synthase activity (16.3 U/g wet weight, in
controls 14.1  4.3). Sequencing of the mitochondrial DNA from the
skeletal muscle biopsy revealed a novel heteroplasmic mutation
(m.4279A>G) in the MT-TI gene coding for the mitochondrial tRNAIle
(Fig. 2A). This mutation is changing a highly conserved nucleotide in
the DHU-loop of this particular tRNA (Fig. 2B; the position is identical
in all species of a consensus panel proposed by Yarham et al.)8. The
nucleotide exchange m.4279A>G was not present in 8466 publicly
available complete human mtDNA sequences (NCBI Nucleotide
Sequence Database). All other differences from the reference
sequence found were known homoplasmic polymorphisms. The
degree of heteroplasmy of the novel mitochondrial DNA mutation
was 70% in skeletal muscle and 15% in blood (Fig. 2C). The mutation
was not detected in the blood of the patient’s healthy brother. To
obtain evidence on the pathogenicity of the m.4279A>G mutation,
we investigated the correlation of mutation loads with the
biochemical phenotype in single skeletal muscle ﬁbres. We found
that ﬁbres that carried the mutation in less than 90% of their mtDNA
molecules did not display an altered function of cytochrome c
oxidase, whereas a dysfunctional respiratory chain was observed in
ﬁbres harbouring nearly exclusively mutant mtDNA (Fig. 2D). This
very high threshold is typical for many pathogenic mitochondrial
tRNA mutations.
4. Discussion
PMEs are rare entities in adult epilepsy centres. One of the
most common forms in adulthood might be MERRF, which is an
important differential diagnosis in patients with prominent
myoclonic seizures. Mitochondrial tRNA mutations often display
lower degrees of heteroplasmy in blood than in postmitotic
tissues,4 as in our case (15% versus 70% in muscle). Therefore,
genetic analysis of the muscle biopsy is essential for the
diagnosis. Valproic acid can deteriorate the condition of patients
with mitochondrial diseases since it inﬂuences the mitochondrialof the mitochondrial tRNAIle gene from skeletal muscle DNA of the index patient. The
ructure of the mitochondrial tRNAIle. The mutated position observed in the patient is
ion load in blood compared to muscle. BL, blood samples from the patient and his
ant. (D) Correlation of COX/SDH activity ratios with m.4279A>G mutation loads in
ow a relevant dysfunction of cytochrome c oxidase. Horizontal error bars indicate
s were distinguished based on myosin ATPase staining at pH 4.6 and 9.4, and are
iratory chain dysfunction.
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avoided in such patients. On the other hand, valproic acid is the
ﬁrst medication chosen in patients with myoclonia underlining
the early necessity for a genetic diagnosis. Our case fulﬁlled the
classical characteristics of MERRF, however, we did not ﬁnd the
common mutation, m.8344A>G. Instead, we identiﬁed a novel
mutation, m.4279A>G, in the mitochondrial tRNAIle gene as the
underlying cause of the disease. We provided evidence support-
ing the functional relevance of the mutation by showing a
correlation between genotype and biochemical phenotype in
single muscle ﬁbres. This mutation has not been reported in the
literature before. According to the revised pathogenicity scoring
system for mitochondrial tRNA mutations,9 our investigations
classify the m.4279A>G mutation as deﬁnitely pathogenic
(evolutionary conservation: 2 points, heteroplasmy: 2 points,
histochemical evidence: 2 points, biochemical defect: 2 points,
single-ﬁbre analysis: 3 points, total: score 11). The clinical
picture in patients with the previously described 14 tRNAIle
mutations is dominated by chronic progressive external
ophthalmoplegia (CPEO), but also progressive hearing loss and
cardiomyopathy have been reported.10 In two cases, also
generalized tonic–clonic seizures were described.11,12 Myoclonic
epilepsy was not reported before in patients with tRNAIle
mutations. Our case shows, that prominent biochemical altera-
tions and high levels of mtDNA mutations can be detected in
skeletal muscle of a patient with a pure CNS (central nervous
system) phenotype. Therefore, histological and genetic analyses
of a skeletal muscle biopsy are essential for the diagnosis of
myoclonic epilepsy.
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